Cytek Biosciences, Inc. (CTKB) Stock Grade

About Cytek Biosciences, Inc.'s fundamentals

Cytek Biosciences is a medical device company with a market capitalization of $741.3 million that generated minimal revenue growth of 0.5% year-over-year, indicating stagnant sales momentum. The company operates at a significant loss, with a net margin of -33.0%, reflecting substantial expenses relative to revenue and resulting in a net loss for the latest annual period. The company does not pay a dividend, and traditional profitability metrics like P/E ratio and return on equity are not applicable given the unprofitable operating performance.